newsfilter
← Latest News
Business Wire·

Edwards Lifesciences Comments on TAVR National Coverage Decision

EW

Edwards Lifesciences (NYSE:EW) today issued the following statement in response to the national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) released by the Centers for Medicare &